2nd Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,585,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2023 $1,585,000 Replaced
2nd Quarter - Amendment Oct 2, 2023 $1,585,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK —
FRANK DE LIMA New —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)
DAVID TALBOT —

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Patient protection; Drug supply chain and shortages; Drug pricing, coverage, value and access; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Affordable Insulin Now Act (S.3700/HR.6833), The INSULIN Act

LobbyistCovered position, as disclosed
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA)

Bills named: S. 3700 (118th), H.R. 6833 (118th), H.R. 5376 (118th)

Medicare/Medicaid MMM

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; The INSULIN Act

LobbyistCovered position, as disclosed
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 5376 (118th)

Consumer Issues/Safety/Products CSP

Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK —
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)
DAVID TALBOT —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Pharmaceutical intellectual property issues

LobbyistCovered position, as disclosed
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax

LobbyistCovered position, as disclosed
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Hospital discounts; 340B program

LobbyistCovered position, as disclosed
FRANK DE LIMA —
SARAH KYLE Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)
JUAN MACHADO Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)
ASKIA SURUMA Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.